Impact of Gov't Shutdown on Biopharma

Unless a drugmaker has an upcoming PDUFA date or a meeting scheduled with the FDA, chances are the impact would be minimal – provided the shutdown is only short term.

The last shutdown of nonessential government programs lasted more than three weeks, from Dec. 16, 1995, to Jan. 6, 1996.

By law, the FDA may continue activities funded by user fees and carryover money. The Patent and Trademark Office, for example, said it has sufficient prior year reserve fee collections to operate for about four weeks.

Given the vital role federal agencies play in drug R&D, the full impact of the shutdown on biopharma remains to be seen. Read the full bioworld.com story here.

Join the discussion

We welcome your thoughtful comments. Please comply with our Community rules.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments